Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HMB002 for Pediatric Acute Liver Failure
NCT05491135Phase 2Not yet recruiting
- Sponsor
- King's College Hospital
- Start
- Sep 2022
- Primary completion
- Nov 2025
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of HMB-002 in acute liver failure (ALF), sponsored by King's College Hospital. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
HMB-002
03
Conditions
acute liver failure (ALF)
Beyond the preview
Go deeper on NCT05491135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05491135.